J7180 Factor xiii anti-hem factor
Also known as: Factor XIII, fibrin-stabilizing factor, antihemophilic factor
Injection of Factor XIII (fibrin-stabilizing factor), an antihemophilic factor, used to prevent bleeding in Factor XIII deficiency.
In Plain Language
clotting factor replacement; fibrin stabilization
Clinical Context
Indicated for treatment and prophylaxis of bleeding in congenital or acquired Factor XIII deficiency.
RVU Information
CPT J7180 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7180?
CPT J7180 (Factor xiii anti-hem factor) is a J Codes (Drugs) code. Injection of Factor XIII (fibrin-stabilizing factor), an antihemophilic factor, used to prevent bleeding in Factor XIII deficiency.
How is J7180 administered?
CPT J7180 is administered by a healthcare provider, typically via injection or infusion. Indicated for treatment and prophylaxis of bleeding in congenital or acquired Factor XIII deficiency. It is used by Hematology, Surgery, Critical Care.
When is CPT J7180 used?
Indicated for treatment and prophylaxis of bleeding in congenital or acquired Factor XIII deficiency.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.